Li et al. described amplifications of the CDK4, CDK6, CCND1 (or cyclin D1) and CCND2 (or cyclin D2) genes in primary medulloblastomas [30], raising the possibility of using CDK inhibition to suppress medulloblastoma formation. The gene discussed is CCND1; the disease is medulloblastoma.